Dimerix Bioscience Pty Ltd

1 in Phase 3

Quick facts

Phase 3 pipeline

DMX-200 · Oncology
DMX-200 is a dual VEGF and Ang2 inhibitor that blocks angiogenesis and vascular destabilization to reduce tumor blood supply and improve vascular function.